Kevin Folta, Ph.D., professor and chairman of the Horticulture Sciences Department at University of Florida, has provided inaccurate information and engaged in misleading activities in his efforts to promote genetically engineered foods and pesticides.
His recent lawsuit against The New York Times is the latest in a long line of examples of Dr. Folta’s misleading and deceptive communications.
Dr. Folta sues NY Times and Pulitzer Prize winner for reporting his ties to Monsanto
On Sept. 1, 2017, Dr. Folta filed a lawsuit against The New York Times and Eric Lipton, a three-time Pulitzer Prize winning journalist, claiming they defamed him with a
2015 front-page article that described how Monsanto enlisted academics to oppose the labeling of genetically engineered foods.
Dr. Folta’s lawsuit claims the defendants “misrepresented him as a covertly paid operative of one of the largest and most controversial companies in America, Monsanto,” and that they did so in order to “to further their own ‘anti GMO’ agenda.” According to Dr. Folta’s lawsuit, Lipton “has almost singlehandedly silenced the scientific community from teaching scientists how to communicate.”
The lawsuit claims that Dr. Folta “never received” an “unrestricted grant” from Monsanto and that he “never received any form of grant, and never received support for him to ‘travel around the country and defend genetically modified foods.’” However, documents show that Monsanto provided Dr. Folta with,
in their words, “an unrestricted grant in the amount of $25,000 which may be used at your discretion in support of your research and outreach projects.”
Emails indicate that Monsanto donated the money in response to a
9-page proposal from Dr. Folta, in which he asked Monsanto for $25,000 to fund his “three tiered solution” to the “biotech communications problem.” Proposed activities included traveling each month to a major domestic university to promote GMOs. The money was donated to a food bank after the documents became public.
Dr. Folta’s lawsuit also claims (point 67), “Dr. Folta does not discuss industry products of any sort, he teaches broadly about technology.” Yet he has vouched for the supposed safety of Monsanto’s RoundUp, going so far as to drink the product “to demonstrate harmlessness.” He has
also said he “will do it again.”
In a
Sept. 29, 2015 email, Janine Sikes, University of Florida Assistant Vice President of Public Affairs, wrote to a colleague about Lipton’s NYT story: “for the record I thought the story was fair.”
Quotes from NYT and Eric Lipton’s response to Folta’s lawsuit, from July 2018
motion for final summary judgement:
Mr. Lipton relied on Plaintiff’s own email communications, which were provided to him by UF in response to a public records request. While it may be that Plaintiff, a self-described “public” scientist, would rather not have his associations with industry giants like Monsanto examined, accurate reporting on the records documenting those associations cannot form the basis for a defamation lawsuit. (Page 1)
Among other things, (Folta’s) UF records documented: (1) Plaintiff’s actions in securing a $25,000 “unrestricted grant” from Monsanto—that Plaintiff told Monsanto would not have to be publicly disclosed—to fund talks about GMO science, including the discussion of industry products; (2) Plaintiff’s testifying before governmental bodies in favor of pro-GMO policies; (3) Plaintiff’s interactions with industry, including numerous email communications with industry representatives providing his thoughts about lobbying strategy and describing his efforts to communicate GMO science to the public; (4) his posts for GMOAnswers, an industry-sponsored website; and (5) travel expenses paid by industry, including expenses related to his trip to Monsanto headquarters. (Page 7)
Dr. Folta has repeatedly claimed no association with Monsanto despite his close collaboration with Monsanto
Dr. Folta stated numerous times that he had no connection to Monsanto. Yet
emails reported by The New York Times established that he was in frequent contact with Monsanto and their public relations allies to collaborate on activities to promote genetically engineered foods.
The emails indicate that Monsanto and allies set up media opportunities and lobbying activities for Dr. Folta and worked with him on messaging. In August 2014, Monsanto informed Dr. Folta that he would receive $25,000 to further his promotional activities. The email exchanges suggest a close collaboration:
- In July 2014, a Monsanto executive praised Dr. Folta’s grant proposal and asked four other Monsanto executives to provide feedback to improve it. He wrote, “This is a great 3rd-party approach to developing the advocacy that we’re looking to develop.”
- In August 2014, Dr. Folta responded to the acceptance letter for his grant, “I’m grateful for this opportunity and promise a solid return on the investment.”
- In October 2014, Dr. Folta wrote to a Monsanto executive, “I’m glad to sign on to whatever you like, or write whatever you like.”
Just weeks after the grant details were worked out, Dr. Folta asserted that he had “
no formal connection to Monsanto.” He later said he
received “no research or personal funding” from “Big Ag,” had “
no financial ties to any of the Big Ag companies that make transgenic crops, including Monsanto,” and had “
nothing to do with MON.”
Bayer Funding
9/18 Update: Dr. Folta
contracted with the law firm Clifford Chance representing Bayer AG to serve an a consultant in an arbitration hearing at a rate of $600 per hour for up to 120 hours.
Those documents were made public by
Biofortified, Inc., a GMO promotion group that
said it severed ties with Dr. Folta over his failure to fully disclose the potential conflict of interest.
11/17 Update: Dr. Folta received and
disclosed receiving research funding from Bayer AG (which is in the process of acquiring Monsanto). According to a
document obtained by US Right to Know via FOIA, Bayer sent an award letter to Dr. Folta on May 23, 2017 for a grant for 50,000 Euros (approximately $58,000), for his proposal on “New Herbicide Chemistries Discovered in Functional Randomness.”
Dr. Folta proposed hiding Monsanto money from public scrutiny
“My funding is all transparent,” Dr. Folta
wrote in his blog, but his
proposal to Monsanto to fund his GMO promotional activities concluded with a paragraph advising Monsanto how to donate the money to avoid public disclosure:
“If funded directly to the program as a SHARE contribution (essentially unrestricted funds) it is not subject to IDC and is not in a ‘conflict-of-interest’ account. In other words, SHARE contributions are not publicly noted. This eliminates the potential concern of the funding organization influencing the message.”
Monsanto sent the $25,000 donation as an
unrestricted grant for Dr. Folta.